Tuesday Hold: META Commits $50B to AI Infrastructure and JPM Positions for Record

Tuesday, July 14 — Book Unchanged

What Happened

Tuesday delivered what CNBC aptly called a "toxic stew": the S&P 500 fell 0.77%, the Nasdaq dropped 1.9%, and the VIX climbed from Monday's 15.03 to 17.16. Three forces converged to pressure risk assets simultaneously.

Iran/Hormuz escalation. President Trump reinstated a naval blockade of Iranian shipping and proposed a 20% transit toll on all cargo moving through the Strait of Hormuz. The UN's International Maritime Organization immediately opposed the measure. Energy markets responded sharply: XLE gained 3.01% and Exxon Mobil surged 4.05%. Oil's move is not merely a commodity story — it reprices inflation expectations upward, complicates the Fed's rate-path calculus, and injects a headline uncertainty premium that compresses equity multiples across sectors.

Rising Fed hike probability. Governor Waller told markets the Fed should not "fight the last war" on inflation but explicitly kept rate hikes on the table. Markets are now pricing a July hike as a live possibility. TLT fell another 0.59% and its 20-day momentum of -2.21% confirms the sustained trend. Rising rate-hike odds apply direct multiple pressure to long-duration growth names — a key reason QQQ underperformed SPY by more than a full percentage point today.

AI trade fatigue. NVDA fell 3.52%, AVGO dropped 3.98%, and XLK shed 2.42%. After Monday's rebalance elevated NVDA and META on the TSMC 68% revenue confirmation, today saw rotation out of AI hardware names. This is tactical positioning noise against a strategic signal: TSMC's foundry revenue is realized, audited revenue — it does not become less relevant because NVDA's price fell on Tuesday.

What Countered the Pressure

Not everything sold off, and the counters are thesis-relevant.

META committed $50 billion to AI infrastructure. The Louisiana data center investment announced today is the largest single-state AI infrastructure commitment by any technology company in U.S. history, aided by generous state tax incentives. This is capital deployment, not guidance. META's revenue model runs on proprietary first-party behavioral data processed through its own inference infrastructure. A $50B commitment means META is building its competitive moat in owned compute, not renting it from hyperscalers. Advertisers optimizing for return per dollar on Advantage+ are running on proprietary infrastructure that no competitor can replicate at this scale. The advertising AI thesis is structurally stronger today than it was Monday.

Financials outperformed. XLF gained 0.65% and JPM pulled back only 0.58% despite broad market weakness. The explanation is direct: CNBC reported today that big banks are poised to report booming Q2 revenue driven by SpaceX IPO deal flow and Iran war-driven trading volatility. JPM's commodities derivatives desk, energy hedging flows, and credit volatility franchise benefit from exactly the kind of sustained geopolitical supply disruption playing out in the Strait of Hormuz. JPM reports this week. The position is pre-earnings and the setup has not been stronger since JPM entered the book.

Eli Lilly held. LLY fell only 0.56% in a market that dropped tech nearly 2%. The 60-day momentum at +11.43% remains the strongest read in the candidate universe. No adverse CMS ruling, no biosimilar filing, no pipeline data. GLP-1 demand dynamics are unaffected by Iranian shipping policy or Fed rate-path uncertainty.

Portfolio Decisions

No changes. The book holds its Monday configuration: LLY 27%, META 21%, JPM 20%, NVDA 13%, AMZN 11%, MSFT 8%.

Major resizes require thesis-breaking evidence, not price weakness. Today's moves do not break any thesis in the book.

NVDA's 60-day deteriorated mechanically from +1.25% to -2.35% as a direct consequence of today's -3.52% session. The TSMC 68% June revenue confirmation — the original and ongoing basis for the 13% allocation — is unaltered by intraday NVDA price action. Reducing NVDA today would be reacting to price, not to evidence. The position is monitored: a sustained 60-day below -2% combined with a credible hyperscaler order revision would constitute a real signal.

The temptation to add XLE or XOM on the Iran/Hormuz surge is explicitly outside the portfolio's mandate. The portfolio expresses caution through which growth names it holds and how it sizes them — not by rotating into energy as a geopolitical hedge. XLE's 60-day momentum is essentially flat at +0.08% and XOM's is -1.8%. Today's energy rally is a headline event, not a secular growth thesis.

AMZN and MSFT remain at their current weights. AMZN's 60-day at -2.65% and MSFT's at -3.79% have not improved sufficiently to warrant size increases; neither thesis has broken sufficiently to warrant exits. Waller's rate-hike warning applies additional multiple pressure to MSFT specifically, reinforcing the minimum meaningful weight at 8%.

What Could Break the Thesis

• LLY: Adverse CMS Medicare GLP-1 coverage ruling or credible tirzepatide biosimilar IND from a well-capitalized competitor.
• META: Q2 advertising revenue deceleration, particularly in Advantage+ ROAS metrics, or regulatory action delaying the Louisiana data center deployment.
• JPM: Q2 earnings disappoint on credit losses or net interest margin guidance if the Fed hike path proves more aggressive than currently priced.
• NVDA: A large hyperscaler pulling Blackwell orders, or a credible TSMC revenue revision that contradicts the June foundry data.
• Macro: A July Fed hike accompanied by hawkish forward guidance that forces genuine multiple compression across the growth book.

The VIX at 17.16 remains well below stress territory. The toxic stew is real and the next 48 hours will be shaped by bank earnings. The book is positioned for that catalyst.